0001643495-15-000001.txt : 20150528 0001643495-15-000001.hdr.sgml : 20150528 20150528092337 ACCESSION NUMBER: 0001643495-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150528 DATE AS OF CHANGE: 20150528 EFFECTIVENESS DATE: 20150528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cellective BioTherapy, Inc. CENTRAL INDEX KEY: 0001643495 IRS NUMBER: 473581543 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-240663 FILM NUMBER: 15894098 BUSINESS ADDRESS: STREET 1: 6 DAVIS DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-684-3681 MAIL ADDRESS: STREET 1: 6 DAVIS DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 D 1 primary_doc.xml X0707 D LIVE 0001643495 Cellective BioTherapy, Inc. 6 DAVIS DRIVE RESEARCH TRIANGLE PARK NC NORTH CAROLINA 27709 919-684-3681 DELAWARE None None Corporation true 2015 Thomas F. Tedder 6 Davis Drive Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director Promoter Robert Bonczek 6 Davis Drive Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director Promoter Biotechnology Decline to Disclose 06b false 2015-05-20 false true false 0 2499998 2499998 0 false 2 0 0 0 Proceeds will be used for working capital, which will include normal compensation to executive officers/managers. false Cellective BioTherapy, Inc. Thomas F. Tedder Thomas F. Tedder CEO 2015-05-26